08/21/2025 3:56 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2025 8:31 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
08/18/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
08/08/2025 3:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B5 | |
08/01/2025 8:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2025 8:21 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2025 8:15 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2025 8:10 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025 8:25 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for NRSNW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
04/16/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
04/11/2025 3:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
04/11/2025 3:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
04/07/2025 4:25 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2025 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025 8:13 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
01/06/2025 9:40 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024 3:47 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
12/23/2024 8:04 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2024 10:06 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 1:42 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
12/12/2024 4:08 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/04/2024 7:32 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 3:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
11/22/2024 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
10/31/2024 3:59 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:45 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 7:35 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024 7:30 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 8:35 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024 8:13 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
10/01/2024 5:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
09/30/2024 3:53 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 8:25 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 5:10 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Take a look at this picture ... (Ad) A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all.
Even crazier, this secret accurately called every major financial event in recent history …
Now it's signaling something very scary is about to hit the market again … To find out more about this Great Depression secret … Click here for all the details. |
09/09/2024 5:10 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024 4:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024 6:05 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |